AxoGen AXGN 深 沪
已收盘 08-21 16:00:00 美东时间
50.40
+3.960
+8.53%
华盛通- 最 高51.06
- 今 开46.50
- 成交量 177.97万股
- 最 低 46.24
- 昨 收 46.44
- 总市值 27.10亿
- 52周最高 51.06
- 市盈率 静 --
- 换手率 3.31%
- 52周最低 15.24
- 委 比 30.55%
- 总股本 5376.15万
- 历史最高 56.85
- 量 比 2.08
- 振 幅 10.38%
- 历史最低 1.10
- 每 手 1
- 风险率 9.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
HC Wainwright & Co. Maintains Buy on Axogen, Raises Price Target to $53
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $50 to $53.
07-30 19:12
Axogen Q2 Adj. EPS $0.12 Misses $0.13 Estimate, Sales $69.731M Beat $67.098M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is unchanged from the same period last year. The company reported quarterly sales of $69.731 million which beat the analyst consensus estimate of $67.098 mil...
07-29 19:06
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
Full Transcript: Axogen Q1 2026 Earnings Call
Axogen (NASDAQ:AXGN) released first-quarter financial results and hosted an ear...
04-28 22:18
CommVault, Kforce, AxoGen And Other Big Stocks Moving Higher On Tuesday
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimates. Other gainers include Kforce, Omnicell, and AxoGen.
04-28 22:06
Axogen shares are trading higher after the company reported better-than-expected Q1 sales results.
Axogen shares are trading higher after the company reported better-than-expecte...
04-28 21:07
Earnings Scheduled For April 28, 2026
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
Axogen FY2026 Revenue expected to be at least $270.000M vs $266.219M Est
Axogen (NASDAQ:AXGN) FY2026 Revenue expected to be at least $270.000M vs $266.219M Est
04-28 19:03
Axogen Q1 Adj. EPS $0.07, Inline, Sales $61.457M Beat $57.725M Estimate
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 450 percent increase over losses of $(0.02) per share from the same period last year. The company
04-28 19:01
